Floatz logo

Daunorubicin

Liver Metastases

Fudan UniversityPhase 3Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
73/ 100

Competitive context

36 Active assets in the Liver Metastases cohort.

Asset / SponsorPhaseRating
Irinotecan
Kamya Sankar
Phase 3BB
Eloxatin
Sun Yat-sen University
Phase 3BB
Calcium folinate pentahydrate
Fudan University
Phase 3BB
FLUOROURACILUM
Sun Yat-sen University
Phase 3BB
Ipilimumab
Vastra Gotaland Region
Phase 3B

View all 50 →

Same molecule, other indications

Daunorubicin is also rated in:

acute myeloid leukemia by FAB classificationDormant
BBB
Indicative ·
78 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
77 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →